Natixis Advisors, L.P. Ani Pharmaceuticals Inc Transaction History
Natixis Advisors, L.P.
- $53.5 Billion
- Q4 2024
A detailed history of Natixis Advisors, L.P. transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 18,601 shares of ANIP stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,601
Previous 18,184
2.29%
Holding current value
$1.01 Million
Previous $1.09 Million
5.25%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ANIP
# of Institutions
211Shares Held
19.2MCall Options Held
3.4KPut Options Held
10.8K-
Black Rock Inc. New York, NY2.66MShares$145 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$71.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1MShares$54.7 Million0.03% of portfolio
-
State Street Corp Boston, MA737KShares$40.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY700KShares$38.1 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $950M
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...